Increased levels of circulating arginase I in overweight compared to normal weight adolescents

Pediatric Diabetes

Volumn 15, Issue 1, 2014, Pages 51-56

  Jung, Christian ^a,b   Figulla, Hans R ^b   Lichtenauer, Michael ^b   Franz, Marcus ^b   Pernow, John ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Adolescents; Arginase; Cardiovascular risk factors; Cytokines; Obesity; Overweight

Indexed keywords

ARGINASE 1; C REACTIVE PROTEIN; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHILDHOOD OBESITY; CLINICAL ARTICLE; CLINICAL STUDY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; FAMILY HISTORY; GERMANY; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST TO HEIGHT RATIO;

ADOLESCENTS; ARGINASE; CARDIOVASCULAR RISK FACTORS; CYTOKINES; OBESITY; OVERWEIGHT;

ADOLESCENT; ARGINASE; CARDIOVASCULAR DISEASES; HUMANS; MALE; OVERWEIGHT; WAIST CIRCUMFERENCE;

EID: 84893638504     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12054     Document Type: Article

References (38)

1. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA 2006: 295: 1549-1555.
2. Dietz WH, Robinson TN. Overweight children and adolescents. N Engl J Med 2005: 352: 2100-2109.
3. Fagot-Campagna A, Pettitt DJ, Engelgau MM et al. Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000: 136: 664-672.
4. McCarthy HD. Body fat measurements in children as predictors for the metabolic syndrome: focus on waist circumference. Proc Nutr Soc 2006: 65: 385-392.
5. Jung C, Fischer N, Fritzenwanger M, Figulla HR. Anthropometric indices as predictors of the metabolic syndrome and its components in adolescents. Pediatr Int 2010: 52: 402-409.
6. Akinci G, Coskun S, Akinci B et al. Atherosclerosis risk factors in children of parents with the metabolic syndrome. Atherosclerosis 2007: 194: e165-e171.
7. Skilton MR, Celermajer DS. Endothelial dysfunction and arterial abnormalities in childhood obesity. Int J Obes (Lond) 2006: 30: 1041-1049.
8. Bauersachs J, Widder JD. Endothelial dysfunction in heart failure. Pharmacol Rep 2008: 60: 119-126.
9. Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharmacol Physiol 2007: 34: 906-911.
10. Jung C, Gonon AT, Sjoquist PO, Lundberg JO, Pernow J. Arginase inhibition mediates cardioprotection during ischaemia-reperfusion. Cardiovasc Res 2010: 85: 147-154.
11. Gonon AT, Jung C, Katz A et al. Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production. PLoS One 2012: 7: e42038.
12. Gronros J, Jung C, Lundberg JO, Cerrato R, Ostenson CG, Pernow J. Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 2011: 300: H1174-H1181.
13. Ryoo S, Gupta G, Benjo A et al. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Circ Res 2008: 102: 923-932.
14. Quitter F, Figulla HR, Ferrari M, Pernow J. Jung C. Clin Hemorheol Microcirc: Increased arginase levels in heart failure represent a therapeutic target to rescue microvascular perfusion, 2012.
15. Johnson FK, Johnson RA, Peyton KJ, Durante W. Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 2005: 288: R1057-R1062.
16. Shemyakin A, Kovamees O, Rafnsson A et al. Arginase inhibition improves endothelial function in patients with coronary artery disease and type 2 diabetes. Circulation 2012: 126: 2943-2950.
17. Kim OY, Lee SM, Chung JH, Do HJ, Moon J, Shin MJ. Arginase I and the very low-density lipoprotein receptor are associated with phenotypic biomarkers for obesity. Nutrition 2012: 28: 635-639.
18. Gao X, Xu X, Belmadani S et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol 2007: 27: 1269-1275.
19. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care 2007: 30: 3105-3109.
20. Zimmet P, Alberti KG, Kaufman F et al. The metabolic syndrome in children and adolescents - an IDF consensus report. Pediatr Diabetes 2007: 8: 299-306.
21. Jung C, Gerdes N, Fritzenwanger M, Figulla HR. Circulating levels of interleukin-1 family cytokines in overweight adolescents. Mediators Inflamm 2010: 2010: 958403.
22. Kromeyer-Hauschild K, Wabitsch M, Kunze D et al. Perzentile für den body-mass-index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschr Kinderheilkd 2001: 149: 807-818.
23. Kromeyer-Hauschild K, Dortschy R, Stolzenberg H, Neuhauser H, Rosario AS. Nationally representative waist circumference percentiles in German adolescents aged 11.0-18.0years. Int J Pediatr Obes 2011: 6: e129-e137.
24. Serdula MK, Ivery D, Coates RJ, Freedman DS, Williamson DF, Byers T. Do obese children become obese adults? A review of the literature. Prev Med 1993: 22: 167-177.
25. The NS, Suchindran C, North KE, Popkin BM, Gordon-Larsen P. Association of adolescent obesity with risk of severe obesity in adulthood. JAMA 2010: 304: 2042-2047.
26. Srinivasan SR, Bao W, Wattigney WA, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: the Bogalusa Heart Study. Metabolism 1996: 45: 235-240.
27. Lakshman R, Elks CE, Ong KK. Childhood obesity. Circulation 2012: 126: 1770-1779.
28. Park MH, Falconer C, Viner RM, Kinra S. The impact of childhood obesity on morbidity and mortality in adulthood: a systematic review. Obes Rev 2012: 13: 985-1000.
29. Erdely A, Kepka-Lenhart D, Salmen-Muniz R et al. Arginase activities and global arginine bioavailability in wild-type and ApoE-deficient mice: responses to high fat and high cholesterol diets. PLoS One 2010: 5: e15253.
30. Ming XF, Rajapakse AG, Yepuri G et al. Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species. Contributing to insulin resistance and atherogenesis. J Am Heart Assoc 2012: 1: e000992.
31. Ji Y, Sun S, Xia S, Yang L, Li X, Qi L. Short term high fat diet challenge promotes alternative macrophage polarization in adipose tissue via natural killer T cells and interleukin-4. J Biol Chem 2012: 287: 24378-24386.
32. Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients. Diabetes Metab 2000: 26: 178-182.
33. Breslin WL, Johnston CA, Strohacker K et al. Obese Mexican American children have elevated MCP-1, TNF-alpha, monocyte concentration, and dyslipidemia. Pediatrics 2012: 129: e1180-e1186.
34. Goral J. TNF-alpha and carbohydrate and lipid parameters in overweight and obese children. Ann Acad Med Stetin 2008: 54: 14-21.
35. Gronros J, Kiss A, Palmer M, Jung C, Berkowitz D. Pernow J. Arginase inhibition improves coronary microvascular function and reduces infarct size following ischemia-reperfusion in a rat model. Acta Physiol (Oxf) 2013: 208: 172-179.
36. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res 2013: 98: 334-343.
37. El-Bassossy HM, El-Fawal R, Fahmy A. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol 2012: 57: 194-200.
38. Yao L, Chandra S, Toque HA et al. Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout. Cardiovasc Res 2013: 97: 509-519.